Cargando…
A spliced form of CD44 expresses the unique glycan that is recognized by the prostate cancer specific antibody F77
Prostate cancer is the most common cancer occurring in men in the United States. The monoclonal antibody F77 that was originally developed in our laboratory recognizes mainly glycolipids as well as O-linked glycosylation on proteins in prostate cancer cells. We have identified a spliced form of glyc...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790488/ https://www.ncbi.nlm.nih.gov/pubmed/29423071 http://dx.doi.org/10.18632/oncotarget.23341 |